Nutrien Ltd.

# Investment Summary: Nutrien Ltd. (NTR) This genomics research identifies molecular markers in pigs associated with improved nitrogen use efficiency (NUE), potentially enabling selective breeding for animals that convert feed more efficiently into protein. For Nutrien, a major global fertilizer and crop nutrient producer, this could drive commercial demand for specialized nitrogen products tailored to high-efficiency livestock operations, while also supporting the company's animal nutrition segment's competitive positioning. The transcriptomic signatures related to amino acid metabolism offer a pathway for Nutrien to develop precision nutrition solutions targeting the swine industry, though commercialization timelines and adoption rates remain uncertain.

# Investment Analysis Summary **Relevance to Nutrien Ltd.: Not Applicable** This basic research article on yeast histone deacetylase mechanisms has no direct clinical or commercial implications for Nutrien Ltd., a diversified fertilizer and crop nutrient company. The work is fundamental biochemistry without plant physiology, agricultural, or nutritional applications relevant to NTR's business segments (potash, phosphate, nitrogen products, and specialty nutrients). **Investor Takeaway:** This publication should not influence NTR investment decisions. Monitoring should focus instead on commodity pricing, production capacity, agricultural demand cycles, and regulatory developments in NTR's core markets.